Esperite Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Out of Business

  • Employees
  • 72

Employees

  • Latest Deal Type
  • Liquidation

Esperite General Information

Description

Operator of a healthcare company intended for innovative medical advancements. The company's operations include extracting and storing adult human stem cells, research and development for therapeutic applications, predictive medicine insights, and other specialized services, enabling patients and healthcare providers to access technologies for stem cell preservation, genetic diagnostics, and personalized treatment strategies.

Contact Information

Website
www.esperite.com
Formerly Known As
Cryo-Save Group
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Herengracht 282
  • 1016 BX Amsterdam
  • Netherlands
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Herengracht 282
  • 1016 BX Amsterdam
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Esperite Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Bankruptcy: Liquidation 14-Apr-2020 Completed Bankruptcy: Liquidation
2. IPO 06-Nov-2007 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Esperite’s complete valuation and funding history, request access »

Esperite Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Esperite Investments & Acquisitions (5)

Esperite’s most recent deal was a Merger/Acquisition with Cryo-Save South Africa. The deal was made on 16-May-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cryo-Save South Africa 16-May-2018 Merger/Acquisition Laboratory Services (Healthcare)
InKaryo 19-Mar-2015 Merger/Acquisition Outcome Management (Healthcare)
Cryo-Save South Africa 01-Apr-2013 Joint Venture Laboratory Services (Healthcare)
Salus Futura 14-Jul-2009 Merger/Acquisition Other Healthcare Services
Output Pharma Services 01-Jan-2008 Merger/Acquisition Logistics
To view Esperite’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Esperite ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Esperite’s complete esg history, request access »

Esperite Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Cryo-Save South Africa Pretoria, South Africa 2013

Esperite FAQs

  • When was Esperite founded?

    Esperite was founded in 2000.

  • Where is Esperite headquartered?

    Esperite is headquartered in Amsterdam, Netherlands.

  • What is the size of Esperite?

    Esperite has 72 total employees.

  • What industry is Esperite in?

    Esperite’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Esperite a private or public company?

    Esperite is a Private company.

  • What is Esperite’s current revenue?

    The current revenue for Esperite is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process